Episode Details

Back to Episodes

GPT-5.4 Reviews, Oil Spikes, Anthropic's TGIF | Doug DeMuro, Vincenzo Landino, Max Hodak

Episode 423 Published 2 weeks, 4 days ago

Description

(00:57) - GPT-5.4 Reviews
(19:52) - February Jobs Report
(23:17) - Iran Conflict Reshaping Global Capital Flows
(29:49) - 𝕏 Timeline Reactions
(34:14) - U.S. Nationalization: A Short History
(52:30) - Dario Apologizes for Leaked Memo
(58:45) - WSJ Mansion Section
(01:23:32) - Vacheron: Culture Over Volume
(01:31:10) - 𝕏 Timeline Reactions
(01:41:12) - Vincenzo Landino is an entrepreneur, speaker, and host of the Brand Boost Podcast, as well as the co-founder and Creative Director of Aftermarq, a video strategy consultancy specializing in brand storytelling through video and live streaming. He discusses Apple's strategic partnership with Formula 1, highlighting how Apple leverages its extensive ecosystem—including devices like iPhones, iPads, and services such as Apple TV—to enhance the F1 fan experience. Landino also explores the integration of F1 content across Apple's platforms, such as detailed circuit maps in Apple Maps and driver-curated playlists on Apple Music, emphasizing the company's innovative approach to engaging both existing fans and newcomers to the sport.
(02:01:30) - Doug DeMuro, an American automotive YouTuber and entrepreneur, is renowned for his in-depth car reviews and as the founder of the online auction platform Cars & Bids. In the conversation, DeMuro discusses Ferrari's upcoming electric vehicle, expressing skepticism about its design and performance, and highlighting the challenges of electric sports cars in the current market.
(02:40:21) - Max Hodak, a biomedical engineer and entrepreneur, co-founded Neuralink with Elon Musk in 2016 and served as its president until his departure in 2021. He then founded Science Corp., focusing on developing brain-computer interfaces to restore vision. In the conversation, Hodak discusses the company's retinal prosthesis, a chip implanted in the eye that, in clinical trials, enabled patients with age-related macular degeneration to regain the ability to read and recognize faces after years of blindness.
(02:57:23) - 𝕏 Timeline Reactions